In this study, we investigated the effects of an SGLT2 inhibitor Dapagliflozin and HIF-PHI Roxadustat on the expression and distribution of podocyte-specific molecules and cytoskeleton in cultured human podocytes as well as kidney biopsies from human DKD. The gene discussed is SLC5A2; the disease is diabetic kidney disease.